EMA: First-in-class treatment to delay onset of type 1 diabetes. Teizeild significantly delays onset of stage 3 diabetes and preserves functioning of cells producing insulin
14/11/2025
Leggi
Breaking news
Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial
Ziegler AG, Achenbach P, Weiß A, et al.
Lancet. Pub. online 11 Nov 2025.
Leggi
INHALE-1: a multicenter randomized trial of inhaled technosphere insulin in children with type 1 diabetes
Haller MJ, Kanapka L, Monzavi R, et al.
Diabetes Care. Pub. online 12 Nov 2025.
Leggi
Association of HbA1c and an updated glucose management indicator (uGMI) with incident diabetic retinopathy in adults with type 1 diabetes: a longitudinal study
Shah VN, Xu Y, Dabiri Y, et al.
Diabetologia. Pub. online 11 Nov 2025.
Leggi
AIFA: Rapporto OsMed 2024 sull’uso dei farmaci in Italia
10 novembre 2025
Leggi
The use of technology in diabetes in pregnancy: a position statement of expert opinion from the association of medical diabetologists (AMD), the Italian society of diabetology (SID) and the interassociative diabetes and pregnancy study group
Resi V, Bianchi C, Burlina S, et al.
Acta Diabetol. Pub. online 10 Nov 2025.
Leggi
Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection
Jansz TT, Young KG, Hopkins R, et al.
Diabetologia. Pub. online 9 Nov 2025.
Leggi
Toward disease-modifying therapies in type 1 diabetes: focus on teplizumab
Mathieu C, Sims EK, Chatenoud L, et al.
Diabetes Care. Pub. online 6 Nov 2025.
Leggi
Hemoglobin A1c time-in-range, mortality, and diabetes complications in older adults with diabetes
Conlin PR, Prentice JC, Mohr DC, et al.
BMJ Open Diabetes Res Care. Pub. online 4 Nov 2025.
Leggi
Lantidra (donislecel) in type 1 diabetes: an in-depth analysis of pharmacology, clinical effectiveness, safety, and the therapeutic role of the first FDA-approved allogeneic islet cell therapy
Erbasan E, Aliciaslan M, Erendor F, et al.
Diabet Med. Pub. online 11 Nov 2025.
Leggi